Spiro-lactam NMDA receptor modulators and uses thereof
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
1. A compound represented by:
and stereoisomers and pharmaceutically acceptable salts thereof.
2. A pharmaceutical composition comprising the compound of claim 1 , and a pharmaceutically acceptable excipient.
3. The pharmaceutical composition of claim 2 , suitable for oral administration.
4. The pharmaceutical composition of claim 2 , suitable for intravenous administration.
5. A method of treating a migraine in a patient in need thereof, comprising administering to said patient a pharmaceutically effective amount of a compound of claim 1 .
6. A method of treating neuropathic pain in a patient in need thereof, comprising administering to said patient a pharmaceutically effective amount of a compound of claim 1 .
7. A method of treating traumatic brain injury in a patient in need thereof, comprising administering to said patient a pharmaceutically effective amount of a compound of claim 1 .